Platelet hyperaggregability persists even after the improvement of increased blood coagulation and impaired fibrinolysis with the stabilization of symptoms in patients with unstable angina
S. Miyamoto et al., Platelet hyperaggregability persists even after the improvement of increased blood coagulation and impaired fibrinolysis with the stabilization of symptoms in patients with unstable angina, INT J CARD, 80(2-3), 2001, pp. 235-242
Citations number
36
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background: Platelet aggregation, blood coagulation, and fibrinolysis play
a pivotal role in the pathogenesis of unstable angina. Methods: Platelet ag
gregability was examined on admission and after 2 weeks of treatment in 22
patients with unstable angina, in particular with regard to small-sized pla
telet aggregates, plasma tissue factor (TF) antigen levels as a marker of b
lood coagulation, and plasma plasminogen activator inhibitor (PAI) activity
levels as an indicator of fibrinolysis. We also examined the same paramete
rs in 19 patients with stable exertional angina and 17 patients with chest
pain syndrome. Results: The number of small-sized platelet aggregates incre
ased more significantly in the unstable angina group than in the stable exe
rtional angina and chest pain syndrome groups. In the unstable angina group
, the number of small-sized platelet aggregates decreased significantly aft
er 2 weeks of treatment, but was still higher than that in the stable exert
ional angina and chest pain syndrome groups. Plasma TF antigen and PAI acti
vity were higher in the unstable angina group than in the stable exertional
angina and chest pain syndrome groups. TF and PAI activity decreased to no
rmal ranges after 2 weeks of treatment in the unstable angina group. There
were significant positive correlations among the three parameters on admiss
ion. Conclusions: It was demonstrated that small-sized platelet aggregates,
plasma TF antigen and PAI activity levels increased concomitantly in the u
nstable angina group. While the blood coagulation and fibrinolytic paramete
rs decreased after stabilization of the clinical symptoms, platelet hyperag
gregability still persisted. These results suggest that continuous antiplat
elet therapy is essential for the treatment of unstable angina. (C) 2001 El
sevier Science Ireland Ltd. All rights reserved.